Skip to main content
. 2018 Apr 17;41(8):1189–1204. doi: 10.1007/s00270-018-1959-3

Table 1.

Grading of Recommendations Assessment, Development and Evaluation (GRADE*) [19, 20]

Endpoint Conclusion Literature review GRADE level
Overall survival RFA (± PH) + chemotherapy is superior to chemotherapy alone 1 RCT (downgraded; serious imprecision)a Moderate
RFA + chemotherapy is superior to chemotherapy alone 1 RCT (downgraded 2x; serious indirectnessb and serious imprecision)a Low
RFA (for unresectable CRLM) + PH is equivalent to PH alone Observational comparative studies Very low
RFA alone (for unresectable CRLM) is inferior to PH alone Observational comparative studies Very low
MWA is equivalent to PH 1 RCT (downgraded; very serious risk of bias) Very low
MWA (for unresectable CRLM) + PH is equivalent to PH alone One observational comparative study Very low
Complications RFA alone (for unresectable CRLM) is superior to PH Observational comparative studies Very low
Studies on RFA (for unresectable CRLM) + PH versus PH alone show conflicting results Observational comparative studies
MWA alone is equivalent to PH 1 RCT (downgraded; very serious risk of bias) Very low
Quality of life There are no comparative studies on the effect of RFA or MWA

*GRADE definitions: high quality—further research is very unlikely to change our confidence in the estimate of effect (randomized controlled trials); moderate quality—further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate (controlled trials, no randomization), low quality—further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate (observational studies); very low quality—any estimate of effect is very uncertain (any other type)

aserious imprecision: in case of low optimal information size (OIS; number of included patients did not meet sample size), dichotomous outcomes, low number of events, wide confidence intervals with uncertainty about magnitude of effect, or when there is a lot of variation in the effects among the participants in continious measures

bserious indirectness: very important differences in populations, interventions, outcome measures, or indirect comparisons